These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 16453936)

  • 1. Setting the record straight: five cancer myths debunked. Cancer experts talk about the most common cancer myths--and why they are erroneous.
    Health News; 2006 Feb; 12(2):7-8. PubMed ID: 16453936
    [No Abstract]   [Full Text] [Related]  

  • 2. Cancer myths. Setting the record straight.
    Mayo Clin Womens Healthsource; 2004 Apr; 8(4):1-2. PubMed ID: 15088017
    [No Abstract]   [Full Text] [Related]  

  • 3. Prognosticating gastric cancer.
    So JB; Yeoh KG
    J Gastroenterol Hepatol; 2009 Sep; 24(9):1478-9. PubMed ID: 19743992
    [No Abstract]   [Full Text] [Related]  

  • 4. Molecular markers for bladder cancer: the road to a multimarker approach.
    Birkhahn M; Mitra AP; Cote RJ
    Expert Rev Anticancer Ther; 2007 Dec; 7(12):1717-27. PubMed ID: 18062746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biological markers in the diagnosis of recurrent bladder cancer: an overview.
    Mohammed A; Khan Z; Zamora I; Bhatti A
    Expert Rev Mol Diagn; 2008 Jan; 8(1):63-72. PubMed ID: 18088231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction of treatment outcome by CD44v6 after total mesorectal excision in locally advanced rectal cancer.
    Peng J; Lu JJ; Zhu J; Xu Y; Lu H; Lian P; Cai G; Cai S
    Cancer J; 2008; 14(1):54-61. PubMed ID: 18303484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. XIAP as a prognostic marker of early recurrence of nonmuscular invasive bladder cancer.
    Li M; Song T; Yin ZF; Na YQ
    Chin Med J (Engl); 2007 Mar; 120(6):469-73. PubMed ID: 17439739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thymidine phosphorylase expression as a prognostic marker for predicting recurrence in primary superficial bladder cancer.
    Aoki S; Yamada Y; Nakamura K; Taki T; Tobiume M; Honda N
    Oncol Rep; 2006 Aug; 16(2):279-84. PubMed ID: 16820903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MAGE-A and NY-ESO-1 expression in cervical cancer: prognostic factors and effects of chemotherapy.
    Napoletano C; Bellati F; Tarquini E; Tomao F; Taurino F; Spagnoli G; Rughetti A; Muzii L; Nuti M; Benedetti Panici P
    Am J Obstet Gynecol; 2008 Jan; 198(1):99.e1-7. PubMed ID: 18166319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Revised guidelines signal that gene expression profiles are coming of age.
    Benowitz S
    J Natl Cancer Inst; 2008 Jul; 100(13):916-7. PubMed ID: 18577742
    [No Abstract]   [Full Text] [Related]  

  • 11. Doubling time of carcinoembryonic antigen is a significant prognostic factor after the surgical resection of locally recurrent rectal cancer.
    Tanaka K; Noura S; Ohue M; Seki Y; Yamada T; Miyashiro I; Ohigashi H; Yano M; Ishikawa O; Murata K; Kameyama M; Imaoka S
    Dig Surg; 2008; 25(4):319-24. PubMed ID: 18818499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Folic acid supplementation and cancer risk: point.
    Kim YI
    Cancer Epidemiol Biomarkers Prev; 2008 Sep; 17(9):2220-5. PubMed ID: 18768486
    [No Abstract]   [Full Text] [Related]  

  • 13. Increased levels of tumor markers in the follow-up of 400 patients with breast cancer without recurrence or metastasis: interpretation of false-positive results.
    Zervoudis S; Peitsidis P; Iatrakis G; Panourgias E; Koureas A; Navrozoglou I; Dubois JB
    J BUON; 2007; 12(4):487-92. PubMed ID: 18067207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating cancer cells: could they be used in the clinic as recurrence markers for gastric and colorectal cancer?
    Hanisch E; Hottenrott C; Roukos DH
    Ann Surg Oncol; 2009 Mar; 16(3):778-9; author reply 780-2. PubMed ID: 19116754
    [No Abstract]   [Full Text] [Related]  

  • 15. Detection of circulating gastric cancer cells in peripheral blood using real time quantitative RT-PCR.
    Koga T; Tokunaga E; Sumiyoshi Y; Oki E; Oda S; Takahashi I; Kakeji Y; Baba H; Maehara Y
    Hepatogastroenterology; 2008; 55(84):1131-5. PubMed ID: 18705345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High local recurrence risk is not associated with large survival reduction after postmastectomy radiotherapy in high-risk breast cancer: a subgroup analysis of DBCG 82 b&c.
    Kyndi M; Overgaard M; Nielsen HM; Sørensen FB; Knudsen H; Overgaard J
    Radiother Oncol; 2009 Jan; 90(1):74-9. PubMed ID: 18471914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Important matters to identify robust markers for metastasis and recurrence in solid cancer.
    Mimori K; Iwatsuki M; Yokobori T; Mori M
    Ann Surg Oncol; 2009 Apr; 16(4):1070-1. PubMed ID: 19169757
    [No Abstract]   [Full Text] [Related]  

  • 18. Bladder cancer diagnosis and recurrence prognosis: comparison of markers with emphasis on survivin.
    Schultz IJ; Witjes JA; Swinkels DW; de Kok JB
    Clin Chim Acta; 2006 Jun; 368(1-2):20-32. PubMed ID: 16480698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anaplastic sarcoma of the kidney: a clinicopathologic study of 20 cases of a new entity with polyphenotypic features.
    Vujanić GM; Kelsey A; Perlman EJ; Sandstedt B; Beckwith JB
    Am J Surg Pathol; 2007 Oct; 31(10):1459-68. PubMed ID: 17895746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biological markers and prognosis in recurrent oral cancer after salvage surgery.
    Agra IM; Carvalho AL; Pinto CA; Martins EP; Filho JG; Soares FA; Kowalski LP
    Arch Otolaryngol Head Neck Surg; 2008 Jul; 134(7):743-9. PubMed ID: 18645125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.